TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Phase 1 Completed
185 enrolled 28 charts
Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer
Phase 2 Completed
34 enrolled 10 charts
IVY
Phase 1 Completed
353 enrolled
Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer
Phase 2 Completed
94 enrolled 10 charts
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
Phase 2 Completed
Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer
Phase 2 Completed
44 enrolled 12 charts
Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
Phase 2 Completed
71 enrolled
Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer
Phase 2 Completed
45 enrolled 11 charts
Perioperative Therapy for Resectable Pancreatic Cancer
Phase 2 Completed
35 enrolled 13 charts
A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer
Phase 2 Completed
37 enrolled 7 charts
Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB)
Phase 2 Completed
46 enrolled 7 charts
Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
Phase 2 Completed
259 enrolled
Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
Phase 1 Completed
21 enrolled 7 charts
Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar
Phase 2 Completed
32 enrolled 6 charts
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers
Phase 2 Completed
50 enrolled 21 charts
Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
Phase 2 Completed
25 enrolled
Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer
Phase 2 Completed
10 enrolled 9 charts
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
Phase 2 Completed
96 enrolled
Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies
Phase 1 Completed
29 enrolled
PACT-9
Phase 2 Completed
105 enrolled
The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer
Phase 2 Completed
45 enrolled
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Phase 1 Completed
26 enrolled
Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT
Phase 2 Completed
40 enrolled
Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer
Phase 2 Completed
32 enrolled